HBM HEALTHCARE INVESTMENTS AG

(HBMN)
  Report
Delayed Swiss Exchange  -  11:31 2022-06-29 am EDT
272.00 CHF   -0.18%
06/17Key Figures 15.06.2022
EQ
06/10Shareholders' Meeting of HBM Healthcare Investments approved all proposals by the Board of Directors
EQ
06/10HBM Healthcare Investments AG Approves Distribution, Payable on 1 September 2022
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Publication of Annual Report 2021/2022 and Invitation to the Ordinary Shareholders? Meeting

05/18/2022 | 12:49am EDT

HBM Healthcare Investments AG / Key word(s): Annual Results
Publication of Annual Report 2021/2022 and Invitation to the Ordinary Shareholders? Meeting

18-May-2022 / 06:46 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.


The invitation to the 21st Ordinary Shareholders? Meeting on 10 June 2022 has been sent to the shareholders of HBM Healthcare Investments today.

In accordance with the Ordinance on Measures to Combat the Coronavirus, issued by the Swiss Federal Council, the shareholders are not permitted to participate in person. All shareholders are kindly asked to exercise their rights exclusively through the independent proxy by way of written or electronic instruction and power of attorney.

The detailed invitation with all motions of the Board of Directors is displayed on the Company?s website www.hbmhealthcare.com/en/investors/shareholders-meeting.

Agenda for the 21st Ordinary Shareholders? Meeting on 10 June 2022

  1. Statutory financial statements and group financial statements 2021/2022; reports of the auditors
     
  2. Discharge from liability of the members of the Board of Directors and Management
     
  3. Appropriation of results
    - Appropriation of disposable profit of CHF 327'937'326.
     
  4. Elections regarding the Board of Directors
    - Re-elections of the Chairman and of the Members of the Board of Directors
    - Re-elections of the Members of the Compensation Committee
     
  5. Compensation to the Board of Directors and to the Management
     
  6. Appointment of auditors
     
  7. Appointment of independent proxy-holder
     
  8. Reduction of share capital: partial payback of nominal value
    - Cash distribution to shareholders of CHF 9.70 per share through nominal value repayment
     
  9. Approval of a new share buy-back programme and capital reduction in principle
     
  10. Miscellaneous

HBM Healthcare Investments also published today its Annual Report 2021/2022 on the Company?s website www.hbmhealthcare.com/en/investors/financial-reports.

Contact
For further information, please contact Dr Andreas Wicki on +41 41 710 75 77, or at andreas.wicki@hbmhealthcare.com.



End of ad hoc announcement
Language: English
Company: HBM Healthcare Investments AG
Bundesplatz 1
6300 Zug
Switzerland
Phone: +41438887171
Fax: +41438887172
E-mail: info@hbmhealthcare.com
Internet: https://www.hbmhealthcare.com
ISIN: CH0012627250
Valor: 1262725
Listed: SIX Swiss Exchange
EQS News ID: 1355041

 
End of Announcement EQS News Service

1355041  18-May-2022 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1355041&application_name=news&site_id=zonebourse_sftp

© EQS 2022
All news about HBM HEALTHCARE INVESTMENTS AG
06/17Key Figures 15.06.2022
EQ
06/10Shareholders' Meeting of HBM Healthcare Investments approved all proposals by the Board..
EQ
06/10HBM Healthcare Investments AG Approves Distribution, Payable on 1 September 2022
CI
06/03Bristol Myers Squibb to Acquire HBM Portfolio Company Turning Point Therapeutics for US..
EQ
06/01HBM HEALTHCARE INVESTMENTS : Key Figures 31.05.2022
PU
06/01Key Figures 31.05.2022
EQ
05/18HBM Healthcare Investments AG Reports Earnings Results for the Full Year Ended March 31..
CI
05/18Publication of Annual Report 2021/2022 and Invitation to the Ordinary Shareholders? Mee..
EQ
05/16Key Figures 15.05.2022
EQ
05/10Pfizer to acquire HBM portfolio company Biohaven Pharmaceuticals in USD 11.6 billion de..
EQ
More news
Analyst Recommendations on HBM HEALTHCARE INVESTMENTS AG
More recommendations
Financials
Sales 2023 170 M 178 M 178 M
Net income 2023 122 M 128 M 128 M
Net cash 2023 35,0 M 36,7 M 36,7 M
P/E ratio 2023 15,5x
Yield 2023 3,57%
Capitalization 1 892 M 1 984 M 1 984 M
EV / Sales 2023 10,9x
EV / Sales 2024 7,56x
Nbr of Employees 700
Free-Float 82,7%
Chart HBM HEALTHCARE INVESTMENTS AG
Duration : Period :
HBM Healthcare Investments AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HBM HEALTHCARE INVESTMENTS AG
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Last Close Price 272,00 CHF
Average target price 292,00 CHF
Spread / Average Target 7,35%
EPS Revisions
Managers and Directors
Andreas Wicki Chief Executive Officer
Erwin Troxler Chief Financial Officer
Hans-Peter Hasler Chairman
Rudolf Lanz Director
Mario Germano Giuliani Director